BRL-44408
Chemical compound (drug)
Identifiers | |
---|---|
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C13H17N3 |
Molar mass | 215.300 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
| |
NY (what is this?) (verify) |
BRL-44408 is a drug used in scientific research which acts as a selective antagonist for the α2A adrenoreceptor.[1] It has been suggested as having potential therapeutic application in the treatment of extrapyramidal side effects produced by some antipsychotic medications.[2]
References
- ^ Alberts P (January 1993). "Subtype classification of presynaptic alpha 2-adrenoceptors". General Pharmacology. 24 (1): 1–8. doi:10.1016/0306-3623(93)90003-g. PMID 8387042.
- ^ Imaki J, Mae Y, Shimizu S, Ohno Y (April 2009). "Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders". Neuroscience Letters. 454 (2): 143–7. doi:10.1016/j.neulet.2009.03.001. PMID 19429072. S2CID 38109591.
External links
- Media related to BRL-44408 at Wikimedia Commons
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e